Since glucose metabolism is comprehensively involved in the development of cancer in cells and IRF6 was previously implicated in the regulation of glycolysis in other neural cancers, such as glioma [13], we next tested whether IRF6 modulates the glycolytic phenotype in neuroblastoma cells. The gene discussed is IRF6; the disease is cancer.